Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MTX-531 |
Synonyms | |
Therapy Description |
MTX-531 inhibits EGFR and PI3K, which results in decreased Egfr and Pi3k signaling and potentially leads to increased apoptosis and decreased tumor growth (PMID: 38992135). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MTX-531 | MTX531|MTX 531 | EGFR Inhibitor (Pan) 62 PI3K Inhibitor (Pan) 42 | MTX-531 inhibits EGFR and PI3K, which results in decreased Egfr and Pi3k signaling and potentially leads to increased apoptosis and decreased tumor growth (PMID: 38992135). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|